NovoCure (NVCR) Gross Profit Growth (1y) (2015 - 2026)
NovoCure (NVCR) Gross Profit Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 15.59% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 17.10% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 12.38% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 13.54% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 20.50% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 9.82% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 4.20% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 8.95% |
| 10 | NovoCure | 1.99 Bn | 1.55 Bn | 142.48 Mn | 21.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.43% |
| Mar 31, 2026 | 16.01% |
| Dec 31, 2025 | 3.44% |
| Sep 30, 2025 | 2.30% |
| Jun 30, 2025 | 1.41% |
| Mar 31, 2025 | 11.12% |
| Dec 31, 2024 | 26.25% |
| Sep 30, 2024 | 25.72% |
| Jun 30, 2024 | 25.72% |
| Mar 31, 2024 | 13.23% |
| Dec 31, 2023 | 1.69% |
| Sep 30, 2023 | -5.95% |
| Jun 30, 2023 | -18.09% |
| Mar 31, 2023 | -15.71% |
| Dec 31, 2022 | -3.85% |
| Sep 30, 2022 | -2.08% |
| Jun 30, 2022 | 7.10% |
| Mar 31, 2022 | 1.39% |
| Dec 31, 2021 | -10.61% |
| Sep 30, 2021 | -0.83% |